Albireo Appoints Jason G. Duncan as General Counsel and Secretary

BOSTON, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Jason G. Duncan as Gene... Biopharmaceuticals, Personnel Albireo Pharma, bile acid modulator, liver disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news